1. Introduction
Circadian rhythms are intrinsic, approximately 24-hour cycles that regulate various physiological processes, including the sleep-wake cycle. These rhythms are governed by molecular clocks in the brain and peripheral tissues, which synchronize with environmental cues such as light and darkness to promote sleep during the night [
1,
2].
Disruptions to these rhythms—due to factors like artificial light exposure, irregular sleep schedules, or hormonal fluctuations—can lead to sleep disorders and have broader implications for physical and mental health [
3].
Sleep disorders are common and can have significant consequences on patients' health and overall quality of life. While certain sleep disorders are more difficult to treat, many can be effectively managed with the appropriate interventions [
4].
Early identification and treatment of these disorders can help improve sleep quality, reduce associated health risks, and enhance daily functioning, contributing to better physical and mental well-being [
5].
Sleep disorders refer to a range of conditions that disrupt normal sleep patterns, making them one of the most prevalent clinical issues encountered. Insufficient or poor-quality sleep can negatively impact physical, mental, social, and emotional well-being. These disorders can diminish overall health, safety, and quality of life [
6].
The circadian system in both animals and humans operates on a cycle that is close to, but not exactly, 24 hours. To stay in sync with external environmental time, this system must be reset daily. In most mammals, this process of entrainment is accomplished through regular exposure to light and darkness [
7].
Lanzafame had proposed that applying low-energy physical forces in specific repetitive frequencies could have profound effects on biological processes, as physiological rhythms and their potential modulation through external radiant energy [
8]. The brain's molecular clocks are linked to the external world via photoreceptors in the eye, which play a major role in influencing mental and metabolic health [
9,
10].
New scientific evidence has deepened understanding of both the crucial role of physiological rhythms and the negative consequences of their disruption [
11,
12]. These findings have provided insight into how the light therapy, also known as Photobiomodulation (PBM), has shown promise in enhancing mitochondrial function, reducing oxidative stress, and modulating inflammatory pathways—mechanisms that may help regulate altered physiological rhythms and support the reestablishment of homeostasis in higher biological systems [
13,
14,
15]. Moreover, it has been highlighted how factors such as the timing, intensity, duration, and wavelength of light can impact the human biological clock, demonstrating that the human circadian system is strongly influenced by light [
16,
17,
18,
19,
20].
Light is made up of elementary, massless particles, called photons, which travel through space at the speed of light. These photons interact with the body, making light an essential biological factor for human well-being. The human body’s biological balance is closely linked to light exposure [
21,
22].
Recently, advances in non-pharmacological sleep interventions have led to increased interest in light-based therapies (near-infrared and ultraviolet light), which are designed to realign circadian rhythms and improve the well-being of many individuals, by enhancing the quality of their sleep [
23,
24,
25].
The Taopatch® (Tao Technologies, Italy) is an innovative nanotechnology device, that utilizes light therapy through the use of quantum dots—nanocrystals. These quantum dots convert the energy into near-infrared and ultraviolet light, which can have beneficial effects on the human body. When these quantum dots are excited by body infrared radiation and sunlight, they convert the energy into multiple wavelengths between 200 nm and 600 nm. In humans, this process functions as a form of specific light therapy, providing beneficial and therapeutic effects on the entire body, without releasing any chemical substances [
26]. Emerging studies have also explored the interaction between peripheral stimuli—such as light, heat, and touch—and the central nervous system. The vagus nerve, which plays a critical role in parasympathetic regulation and stress modulation, can be influenced by sensory input delivered through the skin [
27]. This light is then directed to specific acupuncture points on the body, encouraging it to "remember" how to naturally communicate with itself. This results in numerous health benefits, including improved balance, posture, sleep quality, focus, athletic performance, pain relief, and more [
28]. Light therapy helps reduce stress and modulate the endocrine system by regulating hormonal and biological rhythms, as the body’s sleep-wake cycle [
29]. Light also stimulates vitamin D production, which is crucial for bone health, growth, immune defense, and the prevention of chronic, degenerative, and neurological conditions [
30].
Currently, the Taopatch is gaining popularity as an innovative device that utilizes nanotechnology to promote beneficial effects on the human body.
While studies have explored the effects of such devices on pain [
31], balance and coordination [
32], postural control [
33], and neuro-degenerative diseases [
34,
35], there is no scientific literature available regarding the impact of this device on sleep quality, highlighting the need for further investigation in this area.
Based on these arguments, the aim of this study was to evaluate the effectiveness of nanotechnology devices on sleep quality. More specifically, we hypothesized that the integration of Taopatch® nanotechnology into a specialized pillow, called the "Repose Tao Pillow," would enhance sleep quality by providing optimal support and comfort, and reducing stress during sleep. Marketed as a tool for improving sleep, we further hypothesized that the experimental group would show superior benefits (e.g., in terms of comfort, relaxation, and overall sleep effectiveness) compared to the control group. For the purposes of this research, the sample was composed exclusively of female participants. This decision was based on a thorough review of the existing literature, which consistently reports a higher incidence of sleep problems and shorter sleep duration in women compared to men [
36,
37,
38,
39].
Another noteworthy finding is the cyclic nature of sleep complaints reported by women [
40]. Recent research has uncovered new insights into sleep pathology in women and the crucial role that sex hormones play in regulating sleep and awakenings. Data suggest that during periods of hormonal fluctuations, women are at a higher risk for sleep disorders, including poor sleep quality, sleep deprivation, obstructive sleep apnoea, restless legs syndrome, and insomnia [
41,
42,
43].
During childhood and pre-adolescence, there are no significant differences in sleep patterns between boys and girls; however, the main differences begin to emerge with the onset of the first menstrual cycle. With menarche, ovarian function increases, leading to the cyclical production and release of female hormones (estradiol and progesterone) into the bloodstream. These hormones regulate various homeostatic functions, including those related to the cardiovascular, respiratory, and metabolic systems, as well as the sleep-wake cycle [
44]. As women approach menopause and during the perimenopausal period, physiological hormonal declines can lead to the onset of sleep disturbances. Normally, sleep onset is accompanied by peripheral vasodilation and heat loss through the skin, resulting from reduced activation of noradrenergic vasoconstrictor tone. A drop in core body temperature is known to accompany rapid sleep onset and is closely linked to melatonin secretion. However, in postmenopausal women, this temperature drop is often diminished, as are early morning cortisol levels [
45,
46]. This is particularly relevant given that the circadian regulation of sleep is tightly coupled with melatonin secretion—a hormone produced by the pineal gland in response to darkness. Typically, melatonin levels begin to rise in the evening, promoting the onset of sleep and helping to maintain the body’s internal sleep-wake rhythm. When melatonin secretion is disrupted—whether due to aging, hormonal changes, or lifestyle factors—sleep quality and duration can be significantly affected [
47]. In women, this relationship is further complicated by fluctuations in oestrogen and progesterone across different life stages, including the menstrual cycle, pregnancy, and menopause. These hormonal changes can interact with melatonin production and further disrupt normal sleep regulation [
48].
In summary, the convergence of evidence from chronobiology, hormonal studies, phototherapy, and sensory neuromodulation supports the rationale for exploring the role of nanotechnology-driven light therapy in enhancing sleep quality. However, while the theoretical framework is compelling, empirical data—particularly in the context of sleep—remains limited. Thus, investigating the effects of devices such as the Taopatch® within a sleep-focused paradigm is both timely and necessary to fill existing gaps in the literature.
2. Materials and Methods
2.1. Participants
The study involved 30 female participants, who were selected from the customers of Manufacture Falomo’s Partners in Italy (https://www.manifatturafalomo.com/pillows/). Each partner was asked to choose two customers to test the “Repose Tao” pillow, following the guidelines provided by Tao Technologies. The inclusion criteria were as follows: absence of sleep disorders (e.g., sleep apnea); no use of sleep medications; no shift work (to avoid disruptions to the circadian rhythm); not being new parents, to minimize sleep interruptions; and moderate caffeine consumption, avoiding excessive intake that could affect sleep. Five participants who were receiving physical therapy were excluded from the study.
Twenty-five healthy participants, aged between 40 and 50 years (M = 44.8, SD = 3.44), were randomly assigned to two groups: the experimental group (n = 15) and the control group (n = 10). All participants were fully informed about the study protocols prior to its commencement and provided written informed consent for all tests. The study adhered to the ethical guidelines outlined in the Ethical Code of the University of Palermo, as well as the Code of Ethics approved by the General Assembly of the Italian Association of Psychology on March 27, 2015. All procedures were conducted in compliance with the Declaration of Helsinki, and ethical approval was granted by the University Enna Kore Internal Review Board for psychological research (UKE-IRBPSY-11.25.07).
2.2. Procedures
The study aimed to understand how sleep quality changed over time and whether these changes differed between those using a real (active) pillow and a sham (placebo) pillow. The study utilized a double-blind randomized design, meaning that neither the participants nor the researchers knew who received the real or sham pillow during the study. Participants were asked to report their sleep quality based on their experiences over the past month, following Tao Technologies’ standard guidelines. Sleep quality was assessed three times for each participant: T0 (Baseline), before using the pillow; T1 after one week of using the pillow; T2 after 1 month of use. This allowed the researchers to observe the short-term (T0 → T1) and long-term (T0 → T2) effects of the Repose Tao pillow on sleep quality.
Intervention
The experimental group (n=15) used the “Repose Tao” Falomo pillow, which was equipped with active Taopatch® devices. The pillow is ergonomically designed to support different sleeping positions, particularly for individuals who sleep on their back (supine) or side—positions identified as the most common by the Sleep Foundation (Sleep Foundation - Sleeping Positions). The pillow features four Taopatch® nanotechnology Stripes, each 10 cm long and less than a millimeter thick.
These stripes are strategically positioned on the upper side of the pillow to cover the areas where individuals typically rest their heads during sleep. The arrangement is designed to maximize the interaction time between the integrated nanotechnology and the head during sleep phases. Importantly, the distribution of the nanotechnology stripes is not uniform. To ensure proper usage, a label is placed on one side of the pillow, clearly indicating its correct orientation relative to the user’s body. This labeling ensures the pillow is used correctly and maintains the integrity of the study design.
The control group (n=10) used a placebo pillow that visually resembled the experimental pillow but was fitted with placebo Taopatch® devices that had no active effects.
Additionally, all participants received training on how to use the pillow correctly to ensure consistency in usage across the study sample.
2.3. Measurements
Sleep Quality Assessment
Sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI) [
49], a self-rated questionnaire designed to evaluate sleep quality and disturbances over a one-month period. The PSQI consists of 19 items that generate seven "component" scores: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleeping medication, and daytime dysfunction. Participants are asked to report how frequently they have experienced specific sleep difficulties over the past month and to rate their overall sleep quality. Scores for each item range from 0 to 3, with higher scores indicating more severe sleep disturbances. The PSQI has demonstrated acceptable measures of internal consistency (α = .85) and validity. In the present study, the internal consistency was also good (α = .83).
2.4. Statistical Analysis
The results are expressed as mean ± SD. A repeated measures 3x2 ANOVA was conducted to examine the impact of a specialized pillow (Repose Tao pillow) on sleep quality, as measured by the Pittsburgh Sleep Quality Index (PSQI). The factors were Time (T
0 vs. T
1 vs. T
2) as within-subjects factor and Condition (Experimental Group [EG] using the real pillow vs. Control Group [CG] using the sham pillow) as between-subjects factor. Bonferroni correction was applied to control for multiple comparisons. An effect size was used for each analysis with the eta-squared statistic (
η2) to evaluate the practical significance of findings. The ranges for the interpretation of the effect size based on eta-squared indicated a small effect (0.01), moderate effect (0.06) and large effect (0.14) [
50]. All statistical analyses were conducted using SPSS version 26 (SPSS Inc., Chicago, IL, USA), with significance set at p ≤ .05. The results are presented as mean ± SD.
3. Results
Characteristics of participants are illustrated in
Table 1.
Our data revealed a significant improvement in sleep quality among participants who used the “Repose Tao” pillow with Taopatch® technology, compared to those in the control group. Mean values and standard deviations for each sleep variable across time points and groups are presented in
Table 2.
Subjective sleep quality: There was a significant main effect of time on subjective sleep quality, F(1, 27) = 21.35, p < .01, η² = .20. Post hoc comparisons revealed a significant improvement in the experimental group from T0 (1.2±0.7) to T2 (0.4±0.6), p < .01. The control group also improved, though to a lesser extent, from T0 (1.4±0.8) to T2 (0.8±1.1), p < .05.
Sleep latency: A significant effect of time was also observed for sleep latency, F(1, 27) = 39.06, p < .01, η² = .32. The experimental group demonstrated a reduction from T0 (1.1 ± 0.9) to T2 (0.5±0.5), p < .05. Interestingly, the control group showed an even greater reduction from T0 (1.6±0.5) to T2 (0.1±0.3), p < .01.
Sleep duration: A significant improvement in sleep duration was found across time points, F(1, 27) = 15.31, p < .01, η² = .15. The experimental group improved from T0 (1.3±1.1) to T2 (0.9±0.6), p < .05. While the control group had no significant improvement.
Sleep disturbances: There was a significant time effect for sleep disturbance, F(1, 27) = 11.14, p < .01, η² = .12. The experimental group showed a consistent improvement from T0 (1.4±0.5) to T2 (0.7±0.5), p < .05, while the control group remained relatively stable.
Daytime dysfunction: A strong time effect was found for daytime dysfunction, F(1, 27) = 19.11, p < .01, η² = .17. The experimental group improved from T0 (0.7±0.5) to T2 (0.4±0.6), p < .05. Conversely, the control group worsened over time, increasing from T0 (1.4±0.7) to T2 (2.0±0), p < .05.
Total PSQI score: The overall PSQI score showed a highly significant effect of time, F(1, 27) = 42.35, p < .001, η² = .39. The experimental group demonstrated substantial improvement, decreasing from T0 (6.5±3.9) to T2 (3.2±1.9), p < .01. The control group also improved from T0 (8.7±2.7) to T2 (6.0±1.7), p < .01, although their scores remained significantly higher than the experimental group at T2.
No significant differences were observed between groups in Habitual Sleep Efficiency (p = .82) and Use of Sleeping Medication (p = .10). The Bonferroni post hoc tests confirmed that these changes were statistically significant, especially between T0 and T2. Finally, the total sleep score improved much more in the experimental group, with a very large effect size (η² = .39).
4. Discussion
The purpose of this study was to evaluate the effectiveness of nanotechnology-based devices on sleep quality. Our hypotheses were partially supported by the results, which demonstrated that the “Repose Tao” pillow, incorporating Taopatch® nanotechnology, significantly enhances sleep quality compared to a placebo pillow. The experimental group (real pillow) showed consistent improvements across all sleep dimensions, especially in subjective sleep quality, sleep disturbance, and daytime function. The control group showed some improvements, particularly in sleep latency, but in some areas (like daytime dysfunction), they got worse. The total sleep score improved much more in the experimental group, with a very large effect size.
These findings suggest that integrating nanotechnology into sleep products—such as the “Repose Tao” pillow—may offer a promising non-pharmacological approach to improving sleep quality. The notable reduction in sleep latency indicates that the “Repose Tao” pillow helps users fall asleep more quickly. This effect is particularly valuable for individuals’ experiencing insomnia or delayed sleep phase syndrome, as reduced sleep latency is closely linked to better overall sleep quality [
51,
52]. The contoured shape of the “Repose Tao” pillow is specifically designed to support the natural curvature of the cervical spine, thereby reducing neck strain and promoting a more neutral sleeping posture. This ergonomic advantage is especially beneficial for individuals prone to neck stiffness or discomfort—common factors associated with delayed sleep onset. Additionally, poor spinal alignment during sleep has been linked to frequent awakenings caused by discomfort or pressure points [
53]. By providing optimal support for the head and neck and ensuring even weight distribution, the pillow may help reduce the need for frequent repositioning during the night [
54].
Beyond its ergonomic design, the inclusion of Taopatch® nanotechnology may also contribute to improved sleep outcomes [
55]. The pillow features four strategically positioned Taopatch® strips that interact with key pressure points in the neck and upper head regions. These areas play a crucial role in maintaining spinal alignment and minimizing muscular tension, which may further promote relaxation and support quicker sleep onset [
21,
29].
Optimal postural support—such as that provided by the “Repose Tao” pillow—may also help alleviate common sleep disruptors such as tension headaches, neck pain, and micro-awakenings [
52]. Sleep efficiency, defined as the ratio of time spent asleep to time spent in bed, is a vital indicator of sleep quality. Higher sleep efficiency is associated with enhanced cognitive performance, mood stability, and overall well-being [
56]. Therefore, the combined effect of ergonomic support and nanotechnology in the “Repose Tao” pillow represents a meaningful and innovative intervention for improving both sleep quality and daytime functioning [
57].
Moreover, these benefits may be especially relevant for women, who are disproportionately affected by sleep disturbances, including difficulty falling asleep, frequent awakenings, non-restorative sleep, and vivid or disturbing dreams. This heightened vulnerability highlights the need for targeted, non-invasive interventions that address the underlying physiological and neurological mechanisms of disrupted sleep [
58,
59].
In this context, emerging research suggests that light-based therapies, particularly those delivered through nanotechnology devices, may enhance cellular communication and support systemic regulation in subtle yet meaningful ways [
60,
61].
Limitations and Future Research
Despite its promising findings, this study presents several limitations that should be acknowledged. First, the sample was composed exclusively of female participants without diagnosed sleep disorders, which—while intentional to reduce variability—limits the generalizability of the results to the broader population, including males, older adults, and individuals with clinically diagnosed sleep disturbances.
Second, the relatively short duration of the intervention (one month) may not capture the long-term efficacy of the Repose Tao Pillow or potential habituation effects that may arise with continued use. A longer follow-up period would be necessary to assess whether the observed benefits are sustained over time or diminish due to user adaptation.
Third, the study relied primarily on subjective measures of sleep quality, such as participant-reported comfort and relaxation, which are inherently influenced by individual perception and may introduce reporting bias. The absence of objective sleep data (e.g., actigraphy, polysomnography, or physiological biomarkers) limits the precision of the conclusions regarding sleep architecture and physiological changes.
While the present study examined the effects of the Taopatch®-integrated "Repose Tao" pillow on sleep quality, the underlying physiological mechanisms remain unclear. Future research could investigate how the nanotechnological components interact with biological systems—such as the nervous or endocrine systems—potentially influencing circadian regulation, melatonin production, or autonomic nervous system balance. Further studies could assess the efficacy of the Repose Tao Pillow in populations with diagnosed sleep disorders, such as insomnia, obstructive sleep apnea, or chronic fatigue syndrome. These groups may particularly benefit from non-pharmacological interventions aimed at improving sleep architecture and reducing pain or discomfort. Long-term investigations are also necessary to determine whether the benefits of the pillow are sustained over time. Furthermore, comparative studies between the “Repose Tao” pillow and other sleep aids—such as ergonomic pillows without nanotechnology—would help clarify its relative effectiveness and further validate its role as a non-pharmacological intervention for improving sleep quality. Finally, sleep quality is influenced by environmental factors such as light exposure, climate, and cultural habits. Multi-site studies conducted across different geographic regions and climates could examine the pillow’s effectiveness under diverse living conditions and social norms.
5. Conclusions
The present study aimed to evaluate the effectiveness of a nanotechnology-integrated sleep aid—the Repose Tao Pillow—in improving sleep quality among healthy female participants. The findings suggest that the use of this specialized pillow may contribute to enhanced sleep experiences, particularly in terms of perceived comfort, relaxation, and overall sleep effectiveness. These results support the potential utility of non-pharmacological, technology-driven interventions in addressing sleep-related concerns, especially in populations that are more vulnerable to sleep disturbances, such as women. The “Repose Tao” pillow significantly improves sleep quality by optimizing posture and supporting proper cervical spine alignment, thereby reducing pressure points that commonly disrupt rest. Its contoured design offers effective support for both supine and lateral sleeping positions, promoting balanced weight distribution and preventing muscle strain. Additionally, the integration of Taopatch® nanotechnology may enhance muscle relaxation and proprioceptive feedback, contributing to more stable and restorative sleep.
Overall, this study provides a foundation for continued exploration into the application of nanotechnology in sleep health and highlights the importance of innovative, user-friendly solutions for improving sleep quality in targeted populations.
Author Contributions
Conceptualization, D.D.C. and V.C.F.; methodology, F.C. and F.O.; investigation, G.M.; data curation, F.C. and F.O.; writing—original draft preparation, D.D.C., V.C.F. and G.M.; writing—review and editing, D.D.C., G.M. and F.C. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The study adhered to the ethical guidelines outlined in the Ethical Code of the University of Palermo, as well as the Code of Ethics approved by the General Assembly of the Italian Association of Psychology on March 27, 2015. All participants were informed about the procedures of the study and the anonymity of their answers before providing their written consent to participate, in accordance with the Declaration of Helsinki, and ethical approval was granted by the University Enna Kore Internal Review Board for psychological research (UKE-IRBPSY-11.25.07).
Informed Consent Statement
Informed consent was obtained from all subjects involved in the study.
Data Availability Statement
The data that support the findings of this study are available from the corresponding author (D.D.C.), upon reasonable request.
Conflicts of Interest
The authors declare no conflict of interest.
References
- Reddy, A.B.; O’Neill, J.S. Healthy clocks, healthy body, healthy mind. Trends in cell biology 2010, 20, 36–44. [Google Scholar] [CrossRef] [PubMed]
- Morris, C.J.; Aeschbach, D.; Scheer, F.A. Circadian system, sleep and endocrinology. Molecular and cellular endocrinology 2012, 349, 91–104. [Google Scholar] [CrossRef] [PubMed]
- Taillard, J.; Gronfier, C.; Bioulac, S.; Philip, P.; Sagaspe, P. Sleep in normal aging, homeostatic and circadian regulation and vulnerability to sleep deprivation. Brain sciences 2021, 11, 1003–1022. [Google Scholar] [CrossRef] [PubMed]
- Khoury, J.; Doghramji, K. Primary sleep disorders. Psychiatric Clinics 2015, 38, 683–704. [Google Scholar] [CrossRef]
- Ting, L.; Malhotra, A. Disorders of sleep: an overview. Primary care 2005, 32, 305–319. [Google Scholar] [CrossRef]
- Ohayon, M.M. Epidemiological overview of sleep disorders in the general population. Sleep Med. Res. 2011, 2, 1–9. [Google Scholar] [CrossRef]
- Almeneessier, A.S.; Gupta, R.; Pandi-Perumal, S.R.; BaHammam, A.S. Overview of sleep disorders. In The behavioral, molecular, pharmacological, and clinical basis of the sleep-wake cycle; New York: Academic Press, 2019; pp. 103–122. [Google Scholar]
- Lanzafame, R.J. Editorial: good vibrations: more evidence of reciprocity? Photomed Laser Surg 2007, 25, 465–466. [Google Scholar] [CrossRef]
- Kuehn, B.M. Resetting the circadian clock might boost metabolic health. JAMA 2017, 317, 1303–1305. [Google Scholar] [CrossRef]
- Kramer, A.; Merrow, M. Circadian clocks. Berlin/Heidelberg, Germany: Springer, 2013.
- Foster, R.G.; Kreitzman, L. The rhythms of life: what your body clock means to you! Exp Physiol 2014, 99, 599–606. [Google Scholar] [CrossRef]
- Valverde, A.; Hamilton, C.; Moro, C.; Billeres, M.; Magistretti, P.; Mitrofanis, J. Lights at night: does photobiomodulation improve sleep? Neural regeneration research 2023, 18, 474–477. [Google Scholar]
- Santana-Blank, L.; Rodríguez-Santana, E. Photobiomodulation in Light of Our Biological Clock's Inner Workings. Photomed Laser Surg 2018, 36, 119–121. [Google Scholar] [CrossRef] [PubMed]
- Jung, J.; Kim, T. Photobiomodulation and Its Therapeutic Potential in Sleep Disturbances. Sleep Medicine Research 2024, 15, 218–227. [Google Scholar] [CrossRef]
- Bagnato, V.S.; Rodrigues, T.Z.; Garcia, V.; Vidotti, H.G.M.; Aquino Junior, A.E.D. Systemic effects of photobiomodulation and ultrasound as a potentiating tool in the treatment of sleep disorders: pilot study. J. Nov. Physiother 2024, 14, 1000703–1. [Google Scholar]
- Revell, V.L.; Skene, D.J. Light-induced melatonin suppression in humans with polychromatic and monochromatic light. Chronobiol Int 2007, 24, 1125–1137. [Google Scholar] [CrossRef]
- 17. Zaidi, F.H.; Hull, J.T.; Peirson, S.N.; Wulff, K.; Aeschbach, D.; Gooley, J.J.; Brainard, G.C.; Gregory-Evans, K.; Rizzo, J.F.; Czeisler, C.A.; Foster, R.G.; Moseley, M.J.; Lockley, S.W. Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Curr Biol 2007, 17, 2122–2128. [Google Scholar] [CrossRef]
- Khalsa, S.B.S.; Jewett, M.E.; Cajochen, C.; Czeisler, C.A. A phase response curve to single bright light pulses in human subjects. J Physiol 2003, 549, 945–952. [Google Scholar] [CrossRef]
- Zeitzer, J.M.; Khalsa, S.B.; Boivin, D.B.; Duffy, J.F.; Shanahan, T.L.; Kronauer, R.E.; Czeisler, C.A. Temporal dynamics of late-night photic stimulation of the human circadian timing system. Am J Physiol 2005, 289, R839–R844. [Google Scholar] [CrossRef]
- Chang, A.-M.; Scheer, F.A.; Czeisler, C.A. Adaptation of the human circadian system by prior light history. Sleep 2008, 31, A45–A46. [Google Scholar]
- Glass, G.E. Photobiomodulation: the clinical applications of low-level light therapy. Aesthet. Surg. J. 2021, 41, 723–738. [Google Scholar] [CrossRef]
- Giménez, M.C.; Luxwolda, M.; Van Stipriaan, E.G.; Bollen, P.P.; Hoekman, R.L.; Koopmans, M.A.; Gordijn, M.C. Effects of near-infrared light on well-being and health in human subjects with mild sleep-related complaints: a double-blind, randomized, placebo-controlled study. Biology 2022, 12, 60–83. [Google Scholar] [CrossRef]
- Baig, N.; Kammakakam, I.; Falath, W. Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges. Mater. Adv. 2021, 2, 1821–1871. [Google Scholar] [CrossRef]
- Moro, C.; Valverde, A.; Dole, M.; Hoh Kam, J.; Hamilton, C.; Liebert, A.; Mitrofanis, J. The effect of photobiomodulation on the brain during wakefulness and sleep. Front. Neurosci. 2022, 16, 1–15. [Google Scholar] [CrossRef] [PubMed]
- Elder, G.J.; Flo-Groeneboom, E. How can light be used to optimize sleep and health in older adults? Prog. Brain Res. 2022, 273, 331–355. [Google Scholar] [PubMed]
- Campoli, F.; Iovane, A.; Fabris, A.; Francavilla, V.; Proia, P.; Caprioli, L.; Bonaiuto, V.; Annino, G.; Padua, E.; Messina, G. Acute Effects of Nanotechnological Devices for the Muscle and Joint Pain Treatment. In International Workshop on Engineering Methodologies for Medicine and Sport. Cham: Springer Nature Switzerland, 2024, pp. 86–96.
- Ottaviani, M.M.; Macefield, V.G. Structure and functions of the vagus nerve in mammals. Compr. Physiol. 2022, 12, 3989–4037. [Google Scholar] [CrossRef] [PubMed]
- Terman, M.; Terman, J.S. Light therapy. Principles and practice of sleep medicine 2005, 4, 1424–1442. [Google Scholar]
- Golden, R.N.; Gaynes, B.N.; Ekstrom, R.D.; Hamer, R.M.; Jacobsen, F.M.; Suppes, T.; Nemeroff, C.B. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am. J. Psychiatry 2005, 162, 656–662. [Google Scholar] [CrossRef]
- Gupta, R.; Behera, C.; Paudwal, G.; Rawat, N.; Baldi, A.; Gupta, P.N. Recent advances in formulation strategies for efficient delivery of vitamin D. AAPS pharmscitech 2019, 20, 1–12. [Google Scholar] [CrossRef]
- Gudin, J.A.; Dietze, D.T.; Hurwitz, P.L. Using Nanotechnology to Improve Pain and Function with a Novel, Drug-Free, Topical Pain-Relief Patch: An Interim Analysis. Anesth Pain Res 2020, 4, 1–10. [Google Scholar] [CrossRef]
- Karadjova, M.; Dimitrova, T.; Dobreva, D.; Petrova, J.; Messina, G. Improvement of gait, balance and coordination after application of Taopatch® device. Eur. J. Transl. Myol. 2023, 33, 75–87. [Google Scholar]
- Corna, S.; Aspesi, V.; Clerici, D.; Parisio, C.; Seitanidis, J.; Cau, N.; Capodaglio, P. Effects of nanotechnology-based devices on postural control in healthy subjects. J Sports Med Phys Fitness 2017, 58, 1418–1422. [Google Scholar]
- Messina, G.; Amato, A.; Alioto, A.; Stallone, R.; Rizzo, F.; Ragonese, P.; Proia, P. A new road to improve vitamin D and balance through Taopatch® and proprioceptive protocol in Multiple Sclerosis patients. Eur. J. Transl. Myol. 2022, 32, 10774. [Google Scholar] [CrossRef] [PubMed]
- Krsek, A.; Baticic, L. Nanotechnology-driven therapeutic innovations in neurodegenerative disorders: a focus on Alzheimer’s and Parkinson’s disease. Future Pharmacol 2024, 4, 352–379. [Google Scholar] [CrossRef]
- Lok, R.; Qian, J.; Chellappa, S.L. Sex differences in sleep, circadian rhythms, and metabolism: implications for precision medicine. Sleep Med. Rev. 2024, 75, 101926–101939. [Google Scholar] [CrossRef] [PubMed]
- Zhang, B.; Wing, Y.K. Sex differences in insomnia: a meta-analysis. Sleep 2006, 29, 85–93. [Google Scholar] [CrossRef] [PubMed]
- Baker, F.C.; Yűksel, D.; de Zambotti, M. Sex Differences in Sleep. In: Attarian, H., Viola-Saltzman, M. (eds.) Sleep Disorders in Women. Current Clinical Neurology. Cham: Humana, 2020.
- Fatima, Y.; Doi, S.A.; Najman, J.M.; Al Mamun, A. Exploring gender difference in sleep quality of young adults: findings from a large population study. Clin. Med. Res. 2016, 14, 138–144. [Google Scholar] [CrossRef]
- Meers, J.; Stout-Aguilar, J.; Nowakowski, S. Chapter 3 - Sex differences in sleep health. Grandner, M.A. (ed.) Sleep and Health, New York: Academic Press, 2019, pp. 21–29.
- Baker, F.C.; Driver, H.S. Circadian rhythms, sleep, and the menstrual cycle. Sleep Med 2007, 8, 613–22. [Google Scholar] [CrossRef]
- Owen, J.A. Physiology of the menstrual cycle. Am J Clin Nutr 1975, 28, 333–338. [Google Scholar] [CrossRef]
- Boukari, R.; Laouafa, S.; Ribon-Demars, A.; Bairam, A.; Joseph, V. Ovarian steroids act as respiratory stimulant and antioxidant against the causes and consequences of sleep-apnoea in women. Respir Physiol Neurobiol. 2017, 239, 46–54. [Google Scholar] [CrossRef]
- Caufriez, A.; Leproult, R.; L'Hermite-Baleriaux, M.; Kerkhofs, M.; Copinschi, G. Progesterone prevents sleep disturbances and modulates GH, TSH, and melatonin secretion in postmenopausal women. J Clin Endocrinol Metab. 2011, 96, E614–E623. [Google Scholar] [CrossRef]
- Gomez-Santos, C.; Saura, C.B.; Lucas, J.A.; Castell, P.; Madrid, J.A.; Garaulet, M. Menopause status is associated with circadian- and sleep-related alterations. Menopause. 2016, 23, 682–690. [Google Scholar] [CrossRef]
- Gursoy, A.Y.; Kiseli, M.; Caglar, G.S. Melatonin in aging women. Climacteric. 2015, 18, 790–796. [Google Scholar] [CrossRef] [PubMed]
- Pandi-Perumal, S.R.; Srinivasan, V.; Spence, D.W.; Cardinali, D.P. Role of the melatonin system in the control of sleep: therapeutic implications. CNS drugs 2007, 21, 995–1018. [Google Scholar] [CrossRef] [PubMed]
- Pandi-Perumal, S.R.; Zisapel, N.; Srinivasan, V.; Cardinali, D.P. Melatonin and sleep in aging population. Exp. Gerontol 2005, 40, 911–925. [Google Scholar] [CrossRef] [PubMed]
- Buysee, D.J.; Reynolds, C.F.; Monk, T.H.; Berman, S.R.; Kupfer, D.J. Pittsburgh Sleep Quality Index (PSQI) APA PsycTests, 1989.
- Olejnik, S.; Algina, J. Generalized Eta and Omega Squared Statistics: Measures of Effect Size for Some Common Research Designs. Psychol. Methods. 2003, 8, 434–447. [Google Scholar] [CrossRef]
- Cole, J.C.; Dubois, D.; Kosinski, M. Use of patient-reported sleep measures in clinical trials of pain treatment: a literature review and synthesis of current sleep measures and a conceptual model of sleep disturbance in pain. Clin. Therap. 2007, 29, 2580–2588. [Google Scholar] [CrossRef]
- Katz, J.N.; Chang, L.C.; Sangha, O.; Fossel, A.H.; Bates, D.W. The association of self-reported back pain with sleep disturbance and fatigue: A cross-sectional study of primary care patients. Arch. Intern. Med. 2011, 156, 545–549. [Google Scholar]
- Liebert, A.; Capon, W.; Pang, V.; Vila, D.; Bicknell, B.; McLachlan, C.; Kiat, H. Photophysical mechanisms of photobiomodulation therapy as precision medicine. Biomedicines 2023, 11, 237. [Google Scholar] [CrossRef]
- Wang, X.; Liu, Y.; Zhang, H.; Zhou, Y. Advances in nanotechnology-based sleep aids: Current evidence and future perspectives. J. Sleep Res., 2022, 31, e13562. [Google Scholar] [CrossRef]
- Cole, J.C.; Motivala, S.J.; Buysse, D.J.; Oxman, M.N.; Levin, M.J.; Irwin, M.R. Validation of a 3-factor scoring model for the Pittsburgh Sleep Quality Index in older adults. Sleep 2006, 29, 112–116. [Google Scholar] [CrossRef]
- Cole, C.; Richards, K.C.; Zaslavsky, O. Sleep hygiene and sleep quality in older adults. J. Gerontol. Nurs. 2006, 32, 12–20. [Google Scholar]
- Duffy, J.F.; Wright, K.P. Entrainment of the human circadian system by light. J Biol Rhythms 2005, 20, 326–338. [Google Scholar] [CrossRef] [PubMed]
- Lechat, B.; Scott, H.; Naik, G.; Hansen, K.; Nguyen, D.P.; Vakulin, A.; Eckert, D.J. New and emerging approaches to better define sleep disruption and its consequences. Front Neurol 2021, 15, 1–45. [Google Scholar] [CrossRef] [PubMed]
- Parrino, L.; Halasz, P.; Szucs, A.; Thomas, R.J.; Azzi, N.; Rausa, F.; Mutti, C. Sleep medicine: Practice, challenges and new frontiers. Front Neurol 2022, 13, 1–41. [Google Scholar] [CrossRef] [PubMed]
- Malik, S.; Muhammad, K.; Waheed, Y. Emerging Applications of Nanotechnology in Healthcare and Medicine. Molecules 2023, 28, 1–30. [Google Scholar] [CrossRef]
- Egwu, C.O.; Aloke, C.; Onwe, K.T.; Umoke, C.I.; Nwafor, J.; Eyo, R.A.; Chukwu, J.A.; Ufebe, G.O.; Ladokun, J.; Audu, D.T. Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine. Molecules 2024, 29, 2584. [Google Scholar] [CrossRef]
Table 1.
Participants characteristics. Mean (±SD).
Table 1.
Participants characteristics. Mean (±SD).
| |
Age [Years] |
Height [m] |
Weight [kg] |
| EG |
44.3 ± 3.1 |
1.70 ± 4.85 |
77.7 ± 7.19 |
| CG |
43.4 ± 3.2 |
1.69 ± 4.36 |
69.4 ± 6.77 |
Table 2.
Mean (±SD) for sleep dimensions across session and groups.
Table 2.
Mean (±SD) for sleep dimensions across session and groups.
Sleep Dimensions |
|
T0
|
T1
|
T2
|
F |
η2 |
| Subjective Sleep Quality |
EG |
1.2 ± 0.7 |
0.8 ± 0.6 |
0.4 ± 0.6 ** |
21.35 |
.20 |
| CG |
1.4 ± 0.8 |
0.8 ± 1.1 |
0.8 ± 1.1 * |
| Sleep Latency |
EG |
1.1 ± 0.9 |
0.7 ± 0.8 |
0.5 ± 0.5 * |
39.06 |
.32 |
| CG |
1.6 ± 0.5 |
0.7 ± 0.8 |
0.1 ± 0.3 ** |
| Sleep Duration |
EG |
1.3 ± 1.1 |
0.9 ± 0.7 |
0.9 ± 0.6 * |
15.31 |
.15 |
| CG |
2 ± 0.8 |
1.5 ± 1.1 |
1.2 ± 0.9 |
| SleepDisturbance |
EG |
1.4 ± 0.5 |
1 ± 0.3 |
0.7 ± 0.5 * |
11.14 |
.12 |
| CG |
1.4 ± 0.7 |
1 ± 0.8 |
1.2 ± 0.6 |
| DaytimeDisfunction |
EG |
0.7 ± 0.5 |
0.4 ± 0.5 |
0.4 ± 0.6 * |
19.11 |
.17 |
| CG |
1.4 ± 0.7 |
1 ± 0.5 |
2 ± 0 * |
| TOT |
EG |
6.5 ± 3.9 |
5.8 ± 2.2 |
3.2 ± 1.9 ** |
42.35 |
.39 |
| CG |
8.7 ± 2.7 |
6.2 ± 3 |
6 ± 1.7 ** |
|
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).